Hexapeptide-11

Hexapeptide-11 is a yeast-derived cosmetic peptide studied for skin firmness and cellular aging. Two papers show effects on stress and senescence pathways in cultured human fibroblasts, and one small study measured a narrow elasticity change in people. No trial has shown that it reduces wrinkles, and long-term topical safety remains poorly mapped.

What is hexapeptide-11?

Hexapeptide-11 is a six-amino-acid peptide with the verified sequence phenylalanine-valine-alanine-proline-phenylalanine-proline, shortened to FVAPFP. Researchers describe it as originally isolated from yeast extract, with earlier work tracing the surrounding story to Saccharomyces cerevisiae fermentation. Later experiments used material made by solid-phase synthesis. That makes “yeast peptide skincare” accurate as an origin story, not proof that every finished serum is fermentation-derived.

The identity records deserve unusual restraint. The peer-reviewed sequence is clear, but a dedicated PubChem compound record did not surface, and commercial pages publish conflicting CAS numbers. This profile therefore omits both a PubChem CID and CAS rather than borrowing an identifier from a seller. Six letters are useful; six wrong digits are not.

How does hexapeptide-11 work?

Hexapeptide-11 appears to change the proteostasis network, the cellular housekeeping system that folds proteins, repairs damage, and clears broken material. In cultured human fibroblasts, the 2015 paper reported increased proteasome activity, autophagy and chaperone-related responses, plus more nuclear Nrf2, a regulator of antioxidant defenses. Think of proteostasis as a repair shop and recycling service sharing one loading dock.

The mechanism is not settled. A 2013 study reported reversible, dose-dependent downregulation of ATM and p53, proteins involved in the DNA-damage response and entry into senescence. Reducing a senescence marker in a dish can sound automatically youthful, but p53 is also part of the cell’s damage-control system. No confirmed receptor target explains the full pattern, so the mechanism remains a collection of observed signals rather than a mapped switch.

What does the research actually show?

Hexapeptide-11 has more peer-reviewed work than many cosmetic peptides, but its headline evidence still sits mainly at the in-vitro tier. The 2013 fibroblast paper examined senescence signaling in cultured fibroblasts and dermal papilla cells. The 2015 proteostasis paper found fewer signs of hydrogen-peroxide-induced premature senescence in fibroblasts. Neither experiment measured a wrinkle on a living face.

The 2015 paper also included a half-face assay in 25 volunteers. A toner containing 2.8% hexapeptide-11 was applied twice daily for four weeks. The treated side improved on Ue, the skin’s initial elastic response, but not Uf, its total deformation response. The paper did not report wrinkle depth or a patient-visible outcome, and two authors disclosed employment by personal-care companies. That is a human signal worth preserving, not a wrinkle verdict worth inflating.

A 2021 fibroblast study tested five cosmetic peptides. Hexapeptide-11 alone was associated with a hydroxyproline marker at 400 micrograms per milliliter; the stronger antioxidant and elastin findings came from a four-peptide mixture. Mixture evidence cannot tell which ingredient earned the credit.

What are the realistic hexapeptide-11 benefits for skin?

Hexapeptide-11 benefits are best described as plausible support for cellular stress handling and a preliminary elasticity signal, not demonstrated wrinkle reduction. The lab findings give formulators a reason to keep testing. The small half-face assay gives that work a human foothold. Neither tells a buyer how much younger hexapeptide-11 skin will look, or whether a multi-ingredient product delivers enough active peptide to matter.

This distinction separates hexapeptide-11 senescence research from skincare advertising. Reduced fibroblast senescence in a dish is not the same endpoint as softer crow’s feet. For the broader landscape, see peptides for skin, the cosmetic peptide hub, and Matrixyl, which has a different collagen-signaling mechanism and somewhat more direct human wrinkle evidence.

Is hexapeptide-11 safe? Honest risks

Hexapeptide-11 does not have enough independent human safety research for confident rates of irritation, allergy, or long-term effects. The 2015 study reported no significant toxicity in its cultured fibroblasts, but cells surviving a lab exposure do not establish that a leave-on product is safe for every person. Finished formulas also contain preservatives, fragrance, and other actives that can drive a reaction.

The same paper found increased activity of matrix metalloproteinases MMP-2 and MMP-9 and reduced fibroblast migration. Those findings are not proof of skin harm; their effect in ordinary topical use is unknown. They do show why “activates repair” is too tidy a summary. Proteostasis, senescence, matrix remodeling, and cell movement changed together. No published long-term trial has sorted out the net result.

Is hexapeptide-11 FDA-approved or legal in 2026?

Hexapeptide-11 is legal to use as a US cosmetic ingredient, but it is not an FDA-approved drug active. FDA explains that cosmetics and their ingredients, except color additives, generally do not receive premarket approval. The manufacturer remains responsible for safety, and claims to treat disease can move a product into drug territory.

DailyMed also lists hexapeptide-11 as an inactive ingredient in a marketed topical product; that listing does not make the peptide an approved treatment. For sport, hexapeptide-11 is not named on the 2026 WADA list. USADA says most cosmetic peptides are not prohibited, but athletes remain responsible for checking the exact product and ingredient.

How is hexapeptide-11 used in skincare?

Hexapeptide-11 is used topically in leave-on cosmetic formulas, not as an injectable research protocol. The clearest published human use was the 2.8% toner applied twice daily for four weeks in the 25-person assay. That is a study condition, not a recommended dose, and it cannot be translated cleanly to a serum with a different vehicle or undisclosed active concentration.

The practical buyer question is whether the label actually names Hexapeptide-11 and whether the formula is tolerable as a whole. A long peptide list does not prove an effective concentration. Sunscreen, retinoids, and other well-studied basics still carry the stronger human evidence for visible photoaging; hexapeptide-11 is the early-stage addition whose biology has earned better trials.